Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?

Saved in:
Bibliographic Details
Title: Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?
Authors: Dutt T; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom., Simcox D; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom., Downey C; Liverpool Clinical LaboratoriesLiverpool, United Kingdomand., McLenaghan D; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom., King C; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom., Gautam M; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom., Lane S; University of LiverpoolLiverpool, United Kingdom., Burhan H; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom.
Source: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Aug 01; Vol. 202 (3), pp. 455-457.
Publication Type: Letter; Comment
Journal Info: Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-4970
DOI:10.1164/rccm.202005-1654LE